TaiMed Biologics Inc. (TPEX:4147)
48.05
-0.25 (-0.52%)
Apr 28, 2026, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 13.13 billion as of April 28, 2026. Its market cap has decreased by -45.37% in one year.
Market Cap
13.13B
Enterprise Value
11.85B
Revenue
611.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.05
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 13.13B, an increase of 408.72%. That is a compound annual growth rate of 10.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EirGenix | 13.80B |
| Locus Cell | 12.20B |
| Ever Supreme Bio Technology | 11.61B |
| Polaris Group | 15.01B |
| Medigen Vaccine Biologics | 15.78B |
| Tanvex BioPharma | 10.62B |
| AP Biosciences | 16.73B |
| CHO Pharma | 9.48B |